Study on the angiogenesis of human umbilical cord blood endothelial progenitor cells mediated by Fn14-PI3K-Akt-induced TWEAK

Zulong Sheng,Chengwei Ju,Gaoliang Yan,Zhongpu Chen,Xiaodong Pan,Yanru He,Yangyang Qu,Yuyu Yao,Genshan Ma
DOI: https://doi.org/10.7655/NYDXBNS20180501
2018-01-01
Abstract:Objective:To investigate the effects of tumor necrosis factor-like attenuated apoptosis factor (TWEAK) mediated by Fn14-PI3K-Akt signaling pathway on the proliferation, migration and angiogenesis of human umbilical cord blood derived human endothelial progenitor cells (h EPCs). Methods:h EPCs were isolated and identified in vitro. The h EPCs were treated with Fn14 si RNA and LY294002 (LY), a specific inhibitor of PI3 K. The cells were divided into the control group, the TWEAK treatment group, the TWEAK + Fn14 si RNA blocking group and the TWEAK + LY treatment group. Cell proliferation was measured by CCK-8 assay, cell migration assay was performed in Transwell chamber, and angiogenesis ability was evaluated by Matrigel tubule formation assay. The expressions of p-Akt and T-Akt in cell lysate were measured by Western blot. Results:The h EPCs cultured in vitro showed that TWEAK significantly promoted the proliferation and migration of h EPCs and enhanced the vascularization ability of h EPCs. However, the proliferation, migration and angiogenesis ability of h EPCs in the TEWAK + Fn14 si RNA group and the TWEAK + LY groups were significantly decreased. The expression of p-Akt in the TWEAK group was significantly higher than that in the control group, while the expression of p-Akt in the TWEAK + Fn14 si RNA group and the TWEAK + LY group was significantly lower than that in the TWEAK group. Conclusion:TWEAK can regulate the angiogenesis of h EPCs and its angiogenesis may be restricted by Fn14-PI3 K-Akt signaling pathway.
What problem does this paper attempt to address?